Biolog-id is awarded a contract with IPST funded by the European Commission for the use of Biolog-id Transfusion solution.
IPST, a recognized healthcare institution located in Portugal, decides to adopt the Biolog-id Transfusion solution following a tender awarded to Biolog-id in December 2023.
ALZPROTECT DEVELOPS AN INNOVATIVE TREATMENT AND EXPANDS ITS CLINICAL TRIALS, FOLLOWING VERY POSITIVE RESULT
ADVANCED BIODESIGN, WINNER OF THE FRANCE 2030 PLAN’S CALL FOR “i-DEMO” PROJECTS TO FINANCE ITS “ODYSSEY” CLINICAL TRIAL WITH UP TO €3M
Biolog-id is awarded a multi-year contract with CHMT hospital center for an end-to-end Transfusion solution.
After a successful 6-months pilot project, CHMT decides to adopt all modules of the Biolog Transfusion solution: Encoding, Processing, Transport, Inventory, and X-Match.
Alzprotect announces the extension of Phase 2a clinical trial for the treatment of progressive supranuclear palsy (PSP)
An executive visit of the Global Diwan to learn about the utilisation of Biolog-id’s Transfusion Solution in Kuwait
Paris, France (February 1st, 2023) – Kuwait Blood Transfusion Administration Services (BTAS) is implementing the advanced transfusion solution for blood components traceability developed by Biolog-id, a French digital health company. A delegation of the Global Diwan, an organisation focused on connecting leaders from Europe and the Arab world, met with BTAS management and team on the 31st of January to learn about this exciting East- West collaboration.
ADVANCED BIODESIGN ANNOUNCES THE START OF THE FIRST-IN-HUMAN CLINICAL TRIAL “ODYSSEY” TARGETING ACUTE MYELOID LEUKAEMIA
Biolog-id Announces Deployment of its Value-Chain-Optimization Solution at We Are Blood, a Major Blood Center Serving Central Texas
The deployed solution will provide digital visibility and improved control over multiple points of the value-chain for blood products
Biolog-id Launches an Innovative High-Density (HD) RFID Kit. Targeting the High-Volume Needs of Blood Centers and Large Hospital Blood Banks
Following the successful experience of customers in the US and APAC, the adoption of the HD kit is expanding across multiple geographic regions.